Lipocine Investor Relations Material
Latest events
Status Update
Lipocine
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lipocine Inc
Access all reports
Lipocine Inc. is a biopharmaceutical company focused on the development of oral drug delivery technologies for treating metabolic and endocrine disorders. The company specializes in hormone therapeutics, leveraging its proprietary Liprocol technology to enhance drug absorption and bioavailability. Lipocine's pipeline includes treatments for conditions such as testosterone deficiency, liver disease, and neuroendocrine disorders. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LPCN
Country
🇺🇸 United States